There are currently no events to display.
AcelRx Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute pain.
ACRX (Common Stock)
Data provided by Nasdaq. Minimum 15 minutes delayed.
03/08/18Mar082018 Summary ToggleAcelRx Pharmaceuticals Reports Fourth Quarter 2017 Financial Results
03/08/18Mar082018 Summary ToggleAcelRx announces receipt of Type A FDA meeting minutes and plans to resubmit the DSUVIA New Drug Application in Q2 2018
03/05/18Mar052018 Summary ToggleAcelRx Pharmaceuticals to Participate at Three Upcoming Investor Events in March
March 2018 Corporate Presentation